Amgen v. Sanofi: The fall of the newly characterized antigen test (if it ever truly, jurisprudentially existed in the first place).

Autor: Rein, Frederick Howard, Zalcenstein, Aviv A., McGuinness, Kathleen A.
Předmět:
Zdroj: Journal of Generic Medicines; Sep2019, Vol. 15 Issue 3, p145-154, 10p
Abstrakt: Sanofi's third legal argument, Amgen argued that 16. In addition, Sanofi argued, Amgen had 6. Amgen also dismissed Sanofi's argument that Amgen, and then noted that "In view of the Amgen. [Extracted from the article]
Databáze: Complementary Index